Sangram S. Sisodia

Active 1987–2025

129
Papers
38,569
Citations
100
h-index
128
i10-index

Citations

Citations per year for Sangram S. Sisodia1951: 1 citations1988: 1 citations1990: 15 citations1991: 61 citations1992: 89 citations1993: 91 citations1994: 129 citations1995: 126 citations1996: 198 citations1997: 361 citations1998: 469 citations1999: 591 citations2000: 536 citations2001: 580 citations2002: 668 citations2003: 632 citations2004: 551 citations2005: 624 citations2006: 602 citations2007: 540 citations2008: 513 citations2009: 607 citations2010: 496 citations2011: 569 citations2012: 512 citations2013: 407 citations2014: 437 citations2015: 333 citations2016: 327 citations2017: 363 citations2018: 281 citations2019: 722 citations2020: 868 citations2021: 756 citations2022: 614 citations2023: 501 citations2024: 794 citations2025: 389 citations2026: 4 citations1952–1987: no citations, so these years are not shown1989: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,673 citing papers, 36.4% of this breakdownChina: 1,078 citing papers, 6.9% of this breakdownGermany: 1,057 citing papers, 6.8% of this breakdownUnited Kingdom: 877 citing papers, 5.6% of this breakdownJapan: 658 citing papers, 4.2% of this breakdownCanada: 628 citing papers, 4% of this breakdownItaly: 621 citing papers, 4% of this breakdownFrance: 523 citing papers, 3.4% of this breakdownAustralia: 409 citing papers, 2.6% of this breakdownSpain: 344 citing papers, 2.2% of this breakdownSwitzerland: 308 citing papers, 2% of this breakdownSweden: 302 citing papers, 1.9% of this breakdown
0%36.4%Other 20%

Fields

  • Medicine56.9%
  • Biochemistry, Genetics and Molecular Biology21.2%
  • Neuroscience18.2%
  • Immunology and Microbiology0.8%
  • Nursing0.6%
  • Computer Science0.5%
  • Other1.8%

Topics

  • Alzheimer's disease research and treatments17%
  • Neuroinflammation and Neurodegeneration Mechanisms4.6%
  • Cholinesterase and Neurodegenerative Diseases4.3%
  • Neuroscience and Neuropharmacology Research3.5%
  • Amyotrophic Lateral Sclerosis Research3%
  • Computational Drug Discovery Methods2.9%
  • Other64.7%

Coauthors

All papers

Open in search
  1. The gut microbiome in Alzheimer’s disease: what we know and what remains to be explored

    Authors: , , - Molecular Neurodegeneration 2023 cited by 265

  2. ApoE isoform– and microbiota-dependent progression of neurodegeneration in a mouse model of tauopathy

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Science 2023 cited by 241

  3. Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer’s disease

    Authors: , , , , , , , , , , , , - Scientific Reports 2016 cited by 644

  4. Trafficking and Proteolytic Processing of APP

    Authors: , , , - Cold Spring Harbor Perspectives in Medicine 2012 cited by 1,082

  5. Sex-specific effects of microbiome perturbations on cerebral Aβ amyloidosis and microglia phenotypes

    Authors: , , , , , , , , , , - The Journal of Experimental Medicine 2019 cited by 296

  6. Microglia turnover with aging and in an Alzheimer's model via long-term in vivo single-cell imaging

    Authors: , , , , , , , , , , , , , , - Nature Neuroscience 2017 cited by 417

  7. APP Processing and Synaptic Function

    Authors: , , , , , , , - Neuron 2003 cited by 1,618

  8. Antibiotic-induced perturbations in microbial diversity during post-natal development alters amyloid pathology in an aged APPSWE/PS1ΔE9 murine model of Alzheimer’s disease

    Authors: , , , , , , , , , , , , , - Scientific Reports 2017 cited by 291

  9. Gut microbiota–driven brain Aβ amyloidosis in mice requires microglia

    Authors: , , , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2021 cited by 109

  10. AMPAR Removal Underlies Aβ-Induced Synaptic Depression and Dendritic Spine Loss

    Authors: , , , , , , - Neuron 2006 cited by 1,031

  11. Heterogeneity of CNS myeloid cells and their roles in neurodegeneration

    Authors: , , , - Nature Neuroscience 2011 cited by 676

  12. Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Molecular Neurodegeneration 2024 cited by 57

  13. The gut microbiome regulates astrocyte reaction to Aβ amyloidosis through microglial dependent and independent mechanisms

    Authors: , , , , , , , , , - Molecular Neurodegeneration 2023 cited by 56

  14. Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In Vivo

    Authors: , , , , , , , , , , , , , , , , , , , - Neuron 1996 cited by 1,485

  15. Synergistic depletion of gut microbial consortia, but not individual antibiotics, reduces amyloidosis in APPPS1-21 Alzheimer’s transgenic mice

    Authors: , , , , , , - Scientific Reports 2020 cited by 86

  16. ALS-Linked SOD1 Mutant G85R Mediates Damage to Astrocytes and Promotes Rapidly Progressive Disease with SOD1-Containing Inclusions

    Authors: , , , , , , , , , , - Neuron 1997 cited by 1,330

  17. A mouse model for Down syndrome exhibits learning and behaviour deficits

    Authors: , , , , , , , , - Nature Genetics 1995 cited by 914

  18. Environmental Enrichment Reduces Aβ Levels and Amyloid Deposition in Transgenic Mice

    Authors: , , , , , , , , , - Cell 2005 cited by 878

  19. Increased Type I interferon signaling and brain endothelial barrier dysfunction in an experimental model of Alzheimer’s disease

    Authors: , , , , , , , , , - Scientific Reports 2022 cited by 45

  20. Amyloid beta from axons and dendrites reduces local spine number and plasticity

    Authors: , , , , , - Nature Neuroscience 2009 cited by 360

  21. BAD-mediated neuronal apoptosis and neuroinflammation contribute to Alzheimer's disease pathology

    Authors: , , , , , , , , , , , , , - iScience 2021 cited by 48

  22. β-amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity

    Authors: , , , , , , , , , , , , , , - Cell 1995 cited by 703

  23. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria

    Authors: , , , , , , , , - Neuron 1995 cited by 1,437

  24. Estrogen reduces neuronal generation of Alzheimer β-amyloid peptides

    Authors: , , , , , , , , , , , , , , , , , , - Nature Medicine 1998 cited by 555